1. Preface 
2. International Polices 
2.1 North America 
2.1.1 The United States 
2.1.2. Canada 
2.2 Europe 
2.1.1 Germany 
2.1.2 UK 
2.1.3 France 
2.2 Asia 
2.2.1 China 
2.2.2 Japan 
3. Application Services 
3.1 Virtual Medical Consultation 
3.1.1 Teladoc Health 
3.1.2 AmWell 
3.2 Digital Diagnostics 
3.2.1 Tyto Care 
3.2.2 Healthy.io 
3.3 Digital Pharmacy 
3.3.1 Amazon Care 
3.3.2 
Ali Health 
3.4 Telecare 
3.4.1 Philips eICU 
3.4.2 XR Health 
4. Business Opportunities in Telemedicine Value Chain 
4.1 End Devices: In-home Biometric Devices Have Great Growth Potential 
4.2 Network Communications: Increased Data Transmission in Hospitals Boosts Inelastic Demand 
4.3 Application Services: Telemedicine as a Key Risk Control Technique in the Post-pandemic Era 
5. Key Issues 
5.1 Improvement in Adaptability of Telemedicine Regulations is Required 
5.2 Urgent Needs for Comprehensive Protection of Personal Health Data 
6. MIC Perspective 
Appendix 
List of Companies 

Development of telemedicine around the world, touching on international policies in North America, Europe, and Asia

Telemedicine application services in virtual medical consultation with examples of Teladoc Health and AmWell, in digital diagnostics with examples of Tyto Care and Healthy.io, in digital pharmacy with examples of Amazon Care and Ali Health, and in Telecare with examples of Philips eICU and XR Health

Business opportunities in telemedicine value chain from end devices, network communications, to application services, and includes two key issues in telemedicine

Figure 1 Teladoc Health 
Figure 2 AmWell 
Figure 3 Tyto Care’s Digital Stethoscope 
Figure 4 Healthy.io’s Urine Testing Device 
Figure 5 Amazon Care 
Figure 6 Ali Health 
Figure 7 Philips eICU’s Telecare Center 
Figure 8 XRHealth 
Figure 9 Telemedicine Industry Value Chain 

Table 1 Number of COVID-19 Cases in G7 and BRICS Countries